Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection

Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection

Currently, neutralizing antibody and vaccine strategies have been developed by targeting the SARS-CoV-2 strain identified during the early phase of the pandemic. Early studies showed that the ability of SARS-CoV-2 RBD or NTD antibodies to elicit infection enhancement in vivo is still controversial....

Full description

Bibliographic Details
Main Authors: Song Mu, Shuyi Song, Yanan Hao, Feiyang Luo, Ruixin Wu, Yi Wang, Xiaojian Han, Tingting Li, Chao Hu, Shenglong Li, Meiying Shen, Jingjing Huang, Wang Wang, Yingming Wang, Aishun Jin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Medicine
Subjects:
antibody-dependent enhancement
neutralizing antibody
infection-enhancing antibodies
SARS-CoV-2 variants
receptor-binding domain (RBD)
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.952697/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.952697/full

Similar Items